Directors leading the company include Richard Duce, David Evans, and Chris Waldron.
Although born and bred in Australia, NimbinCann will also operate a second site in Thailand – the lone country in Southeast Asia embracing medical cannabis.
Thailand was chosen not only for its rapid law reforms, but as Managing Director Richard Duce explains, “it has what many call ‘The Goldilocks Conditions’ or the perfect growing conditions for medical cannabis”.
Several key strategic partnerships have already been signed with Thai-based Green Pharma Botanical, Newland Technology, and others. These agreements will grant NimbinCann access to an elite group of cannabis farmers and to one of Thailand’s leading cultivators and retailers of cannabis-infused products.
The Thailand facility aims to produce ~300kg of CBD oil within 7 months of launch, harvesting more than 10,000 plants every month, going on to export the medicines to Australia and beyond.
CGB Price at posting:
2.1¢ Sentiment: None Disclosure: Held